ArticleBMJ open gastroenterology2021

Sitagliptin, a dipeptidyl peptidase-4 inhibitor, in patients with short bowel syndrome and colon in continuity: an open-label pilot study.

Rahim Mohammad Naimi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.